RedCarpetLife
3177
In the world , as of 26 Jan 2026
Cheng Xianfeng

Cheng Xianfeng

C. Xianfeng
$1.01 B ₹ 9,118 Cr
Real Time Net Worth #3177 Ranking as of 26 Jan 2026

More on Cheng Xianfeng

Gender

Male

Age

58Y

Country

China

Born On

January, 1968

Deceased

No

Relationship Status

Unknown

Children

Unknown

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Pharmaceuticals)

Primary Organization

Yifan Pharmaceutical

Titles

Chairman

Sources of Wealth

Pharmaceuticals

Industry

Healthcare, Pharmaceuticals

About Cheng Xianfeng


C heng Xianfeng is the chairman of Yifan Pharmaceutical, a prominent Chinese pharmaceutical company engaged in the research, development, and production of macromolecule biological drugs and chemical medicines. The company, headquartered in Hangzhou, supplies ingredients for skin and healthcare products, as well as feed additives. Cheng has led Yifan's strategic expansion, securing approvals for over 300 drugs across various therapeutic areas including gynecology, pediatrics, and dermatology.

Under his guidance, Yifan has established a global R&D network with centers in San Francisco, Shanghai, Beijing, Hangzhou, and Hefei. The company focuses on developing innovative therapies to address unmet medical needs. Cheng's leadership has been crucial in positioning Yifan as a significant player in both the domestic and international pharmaceutical markets.

Advertisement

Quick Reads


Early Life and Background


Cheng Xianfeng is a Chinese businessman and billionaire, the Chairman of Yifan Pharmaceutical (SZSE: 002019), a major supplier of ingredients for skin and healthcare products, as well as feed additives.

His company, Yifan, has approvals for the sale of more than 300 drugs across diverse therapeutic areas including gynecology, pediatrics and dermatology. Yifan was established in 1990 and is headquartered in Hangzhou, China.

  • Core Company: Yifan Pharmaceutical (SZSE: 002019), specializing in specialty drugs and healthcare products.
  • Sector Focus: Pharmaceuticals, specializing in drugs for gynecology, pediatrics, and dermatology.
  • Geographic Reach: Maintains research centers in San Francisco, Shanghai, Beijing, Hangzhou, and Hefei.

Career Journey of Cheng Xianfeng


Cheng Xianfeng's strategic leadership has driven Yifan Pharmaceutical's growth through diversification into high-value specialty drugs and global R&D. His structural contribution is tied to building a pharmaceutical platform with a strong pipeline and broad regulatory approvals across China.

The company's investment in research centers in both China and the U.S. (San Francisco) highlights a commitment to global standards and R&D excellence. His wealth is derived from his stake in the publicly traded company.

Advertisement

Cheng Xianfeng's Timeline


1990:

Yifan Pharmaceutical's precursor is established.

2000:

Yifan Pharmaceutical is officially founded.

Ongoing:

Serves as Chairman of Directors and General Manager.

Major Business Ventures and Investments


Cheng Xianfeng's wealth is concentrated in his controlling stake and continued leadership of the publicly traded Yifan Pharmaceutical.

  • Yifan Pharmaceutical (SZSE: 002019): Chairman of the company.
  • Products: Ingredients for skin and healthcare products, feed additives, and over 300 approved drugs.
  • R&D Footprint: The company operates research centers across China and in the United States.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He chairs Yifan Pharmaceutical, a major supplier of specialty drugs.
  • Yifan has approvals for the sale of more than 300 drugs.
  • The company maintains research centers in San Francisco, Shanghai, Beijing, Hangzhou, and Hefei.
  • Yifan is listed on the Shenzhen Stock Exchange.

Advertisement

More Profiles


Xu Jinfu & family

-0.14% | -$5.99M

Harley Sy

+0.14% | +$2.30M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content